AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

PROTEOMICS INTERNATIONAL LAB

0.480

+0.0153.23%

Volume:19.88K

Turnover:9.59K

Market Cap:62.88M

PE:-9.32

High:0.490

Open:0.490

Low:0.480

Close:0.465

Loading ...

Overview Company News Filings

Proteomics Opens Certified Clinical Laboratory in California; Shares Fall 8%

MT Newswires Live

Proteomics' Direct-to-Consumer Strategy to Commercialize Diagnostic Tests May Face Delays, Euroz Hartleys Says

MT Newswires Live

BUZZ-Australia's Proteomics International jumps on new stress test for marathon runners

Proteomics International Unit's Muscle Damage Test Shows Potential in Study of Athletes

MT Newswires Live

Australian Shares Inch Down Amid Wall Street Losses; Astral Resources Submits Proposal to Acquire Maximus Resources

MT Newswires Live

ASX Market Close: More red for Oz investors as 2024 drags into station | Dec 30, 2024

The Market Herald

Proteomics International Validates Endometriosis Biomarker for Diagnostic Test; Shares Climb 22%

MT Newswires Live

BUZZ-Australia's Proteomics International jumps on endometriosis panel results

ASX Penny Stock Highlights: Energy Transition Minerals And Two Other Picks

Simply Wall St.

Proteomics International Laboratories (ASX:PIQ) shareholders have earned a 18% CAGR over the last five years

Simply Wall St.

BUZZ-Australia's Proteomics International Laboratories rises on positive cancer study results

Proteomics Investors Face 'Considerable Unknowns' After Kidney Diagnostics License Canceled, Says Euroz Hartleys

MT Newswires Live

Proteomics Investors Face 'Considerable Unknowns' After Kidney Diagnostics License Canceled, Says Euroz Hartleys

MT Newswires Live

Euroz Hartleys Downgrades Proteomics International Laboratories to Hold from Speculative Buy, Adjusts Price Target to AU$0.73 From AU$1.10

MT Newswires Live

Euroz Hartleys Downgrades Proteomics International Laboratories to Hold from Speculative Buy, Adjusts Price Target to AU$0.73 From AU$1.10

MT Newswires Live

ASX Market Update: Mineral Resources leads local bourse higher as US debate draws no Aussie reaction | September 11, 2024

The Market Herald

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/PIQ.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PIQ.AU"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PIQ.AU\",,,,,undefined,":{"symbol":"PIQ.AU","market":"AU","secType":"STK","nameCN":"PROTEOMICS INTERNATIONAL LAB","latestPrice":0.48,"timestamp":1741583520000,"preClose":0.465,"halted":0,"volume":19875,"delay":0,"changeRate":0.032258,"change":0.015,"floatShares":90111464,"shares":131002718,"eps":-0.051492,"lyrEps":-0.050665,"pbRate":11.52,"amount":9591,"amplitude":0.021505,"volumeRatio":0.114404,"dividePrice":0,"prevYearClose":0.8,"fiveDayClose":0.53,"twentyDayClose":0.625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PIQ.AU\",,,,,undefined,":{"symbol":"PIQ.AU","floatShares":90111464,"roa":"-66.25%","roe":"-136.44%","lyrEps":-0.050665,"volumeRatio":0.114404,"shares":131002718,"dividePrice":0,"high":0.49,"amplitude":0.021505,"preClose":0.465,"low":0.48,"week52Low":0.455,"pbRate":"11.52","psRate":"17.99","week52High":1.4,"institutionHeld":0,"latestPrice":0.48,"committee":-0.013322,"eps":-0.051492,"divideRate":0,"volume":19875,"delay":0,"ttmEps":-0.051492,"open":0.49,"prevYearClose":0.8,"prevWeekClose":0.465,"prevMonthClose":0.54,"prevQuarterClose":0.8,"fiveDayClose":0.53,"twentyDayClose":0.625,"sixtyDayClose":0.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PIQ.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PIQ.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PIQ.AU\",pageSize:16,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514393082","title":"Proteomics Opens Certified Clinical Laboratory in California; Shares Fall 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514393082","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514393082?lang=en_us&edition=fundamental","pubTime":"2025-02-28 12:18","pubTimestamp":1740716328,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  has opened a clinical laboratory improvement amendments  certified reference laboratory in Irvine, California, according to a Friday filing with the Australian bourse.The company has secured both a California State License and the CLIA certification, allowing it to operate as a certified clinical laboratory within the US, the filing said.The laboratory will initially offer the PromarkerD test, which predicts diabetes-related chronic kidney disease , and plans to expand with tests for esophageal cancer and endometriosis, the filing added.The launch of PromarkerD, shown to predict DKD up to four years in advance, is expected in the second quarter, the company said.The laboratory is designed for scalability, allowing Proteomics International to introduce additional diagnostic tests efficiently in the US market, the company added.Shares of the company fell 8% in recent Friday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PIQ.AU","BK7048","CLIA","BK7508"],"gpt_icon":0},{"id":"2505337980","title":"Proteomics' Direct-to-Consumer Strategy to Commercialize Diagnostic Tests May Face Delays, Euroz Hartleys Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2505337980","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505337980?lang=en_us&edition=fundamental","pubTime":"2025-01-23 10:39","pubTimestamp":1737599961,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  may face delays in executing its direct-to-consumer strategy in commercializing its diagnostic tests for diabetes, endometriosis, and esophageal cancer, according to a Tuesday note from Euroz Hartleys.The company has reaffirmed its plan for the US launch in the first half of 2025 of its lead diagnostic test PromarkerD for detecting diabetic kidney disease, adding that it remains on track for an Australian launch of the test in the first quarter of 2025.Euroz Hartleys believes that the commercialization could take longer than expected, citing potential execution risks with the direct-to-consumer pathway.Euroz Hartleys notes that the partners in place in other territories have only covered the pre-launch of PIQ's tests in smaller markets.The firm maintained a hold rating and price target of AU$0.72 on Proteomics.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PIQ.AU","BK7048","BK7508"],"gpt_icon":0},{"id":"2495854216","title":"BUZZ-Australia's Proteomics International jumps on new stress test for marathon runners","url":"https://stock-news.laohu8.com/highlight/detail?id=2495854216","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495854216?lang=en_us&edition=fundamental","pubTime":"2024-12-31 08:43","pubTimestamp":1735605797,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Proteomics International jumps on new stress test for marathon runners** Proteomics International Laboratories PIQ.AX jumps as much as 9.5% to A$0.810, highest since Oct. 11** Medical technology firm says its OxiDx test - a finger-prick blood test to measure oxidative stress - accurately identifies muscle damage in marathon runners** PIQ sets sights on H1 CY25 for Australian commercial launch of OxiDx test** More than 540,000 shares traded, 5x the 30-day avg** Stock trims YTD losses to 12.3%  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241231:nL4N3NW00H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","PIQ.AU","BK7048"],"gpt_icon":0},{"id":"2495501179","title":"Proteomics International Unit's Muscle Damage Test Shows Potential in Study of Athletes","url":"https://stock-news.laohu8.com/highlight/detail?id=2495501179","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495501179?lang=en_us&edition=fundamental","pubTime":"2024-12-31 06:28","pubTimestamp":1735597683,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  subsidiary OxiDx's diagnostic testing technology showed a potential to identify muscle damage and recovery among athletes via a finger prick blood test, according to a Tuesday filing with the Australian bourse.Based on a study of 20 marathon runners, the OxiDx diagnostic test was able to measure and assess exercise-induced muscle damage, the filing said.Results were published in the Physiological Reports journal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PIQ.AU","BK7048","BK7508"],"gpt_icon":0},{"id":"2495981605","title":"Australian Shares Inch Down Amid Wall Street Losses; Astral Resources Submits Proposal to Acquire Maximus Resources","url":"https://stock-news.laohu8.com/highlight/detail?id=2495981605","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495981605?lang=en_us&edition=fundamental","pubTime":"2024-12-30 14:05","pubTimestamp":1735538758,"startTime":"0","endTime":"0","summary":"Australian shares inch down Monday's close, tracking Wall Street markets as investors remained uncertain about the new year.The S&P/ASX 200 Index fell 0.3% or 26.8 points to close at 8,231.The day saw thin trading with investors becoming risk-averse ahead of uncertainties surrounding the new year, Bloomberg reported.In company news, Astral Resources  submitted a non-binding indicative proposal to acquire Maximus Resources  for AU$0.07 per share in an all-scrip, off-market takeover. Shares of Astral Resources fell 7%, while shares of Maximus Resources soared 31% at market close.Woolworths Group  said customers of its Everyday car insurance will receive refunds after the retailer discovered they had been overcharged by its underwriter for several years, The Australian reported.Lastly, Proteomics International Laboratories  validated the use of a plasma protein biomarker to detect endometriosis via the PromarkerEndo diagnosis test. The company's shares surged past 22% at market close.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XKO.AU","BK7048","PIQ.AU","XAO.AU","BK7511","BK7104","BK7501","WOW.AU","AAR.AU","BK4106","BK7508","BK7095","MXR.AU","BK7040","XJO.AU","MMS","BK4226"],"gpt_icon":0},{"id":"2495959380","title":"ASX Market Close: More red for Oz investors as 2024 drags into station | Dec 30, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2495959380","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495959380?lang=en_us&edition=fundamental","pubTime":"2024-12-30 13:44","pubTimestamp":1735537440,"startTime":"0","endTime":"0","summary":"The ASX closed down 0.04% on the second last trading day of 2024, losing three points to drop down to 8,221 as slow trade and profit-taking raked markets.The last full day of trading  was awash with red – only two of the 11 sectors on the ASX managed to stay positively green in any real way.Those two up sectors were Energy, up 1.12% at close, and Healthcare, up 0.09%, the latter of which was buoyed by Proteomics International  and its 22.3% rocket up.Real Estate had the biggest dip through today, shedding 1.79%. It was followed by Financials, down 0.51% after the big four banks dropped slightly, and Utilities, dragged down 0.42% by APA Group  and Origin .Boss Energy  and Karoon Energy  both gained today too, up 0.84% and 3.8% respectively after crude oil prices bumped up to start the week.Also among the big winners was coal maker Bowen Coking Coal , up 29%.Join the discussion:Seewhat’s trending right nowon Australia’s largest stock forum and be part of the conversations that move the m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-close-more-red-for-oz-investors-as-2024-drags-into-station-dec-30-2024-2024-12-30/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7507","BK7142","DXS.AU","BK7130","GMG.AU","MXR.AU","BK7510","KAR.AU","GPT.AU","BK7508","BK7083","BK7090","AAR.AU","BK7129","BOE.AU","BK7006","BK7099","APA.AU","BK7104","BK7155","BCB.AU","BK7154","TCL.AU","BK7087","BK7095","ORG.AU","BK7148","PIQ.AU","BK7048","BK7122"],"gpt_icon":0},{"id":"2495561795","title":"Proteomics International Validates Endometriosis Biomarker for Diagnostic Test; Shares Climb 22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495561795","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495561795?lang=en_us&edition=fundamental","pubTime":"2024-12-30 12:14","pubTimestamp":1735532050,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  validated the use of a plasma protein biomarker to detect endometriosis via the PromarkerEndo diagnosis test, according to a Monday filing with the Australian bourse.A recent study showed that the test was able to separate healthy individuals with endometriosis patients using the biomarker, the filing said.Results were published in the journal Human Reproduction, as per the filing.The company's shares surged past 22% in recent Monday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","PIQ.AU","BK7048"],"gpt_icon":0},{"id":"2495517135","title":"BUZZ-Australia's Proteomics International jumps on endometriosis panel results","url":"https://stock-news.laohu8.com/highlight/detail?id=2495517135","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495517135?lang=en_us&edition=fundamental","pubTime":"2024-12-30 09:09","pubTimestamp":1735520973,"startTime":"0","endTime":"0","summary":"** Shares of Proteomics International Laboratories    surge as much as 24% to A$0.750, their biggest one-day pct gain since Oct. 8   ** Medical technology firm reports that its PromarkerEndo plasma protein biomarker panel accurately identifies all stages of endometriosis   ** Endometriosis is a condition causing uterine-like tissue growth outside the uterus, affecting roughly 10% of reproductive age women and girls according to the WHO   ** The condition takes an average of seven years to diagnose   ** PIQ sets sights on Q2 CY25 for Australian launch of its product   ** Stock hits its highest level since Oct. 29   ** Including session's moves, stock trims YTD losses to 19% as of 0050 GMT ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XAO.AU","XJO.AU","BK7508","XKO.AU","PIQ.AU","BK7048"],"gpt_icon":0},{"id":"2491730366","title":"ASX Penny Stock Highlights: Energy Transition Minerals And Two Other Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2491730366","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491730366?lang=en_us&edition=fundamental","pubTime":"2024-12-13 07:08","pubTimestamp":1734044932,"startTime":"0","endTime":"0","summary":"As the ASX 200 faces a potential decline, reflecting broader global market jitters, investors are keenly observing opportunities that may arise amidst these fluctuations. Penny stocks, while often considered niche investments, can still present intriguing growth prospects when backed by strong financial fundamentals. In this context, we will highlight three penny stocks that demonstrate financial resilience and potential for long-term success in the Australian market.Overview: Energy Transition Minerals Ltd is engaged in mineral exploration and evaluation activities in Australia, with a market cap of A$40.85 million.Overview: Proteomics International Laboratories Ltd is a medical technology company specializing in proteomics across Australia, New Zealand, the United States, Europe, India, and South East Asia with a market cap of A$89.08 million.Operations: The company generates revenue of A$3.28 million from its operational activities in the medical techn","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/qUsXHnhTq9BjFq.vX6I3sw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b7362375b2727bfdfe4eb144bcc3fe6a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/qUsXHnhTq9BjFq.vX6I3sw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b7362375b2727bfdfe4eb144bcc3fe6a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-penny-stock-highlights-energy-230852540.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["WC8.AU","BK7023","BK7508","HLO.AU","SHA.AU","MTX","VLS.AU","SRV.AU","BK7070","BK7095","BK7062","BK7164","BK4109","BK7132","MXI.AU","EVO.AU","NGI.AU","BK7133","BK7048","ETM.AU","BK7096","LBL.AU","SKS.AU","XAO.AU","ANG.AU","BK7055","BK7077","PIQ.AU","XKO.AU","BK7088","XJO.AU","BK7506"],"gpt_icon":0},{"id":"2477040170","title":"Proteomics International Laboratories (ASX:PIQ) shareholders have earned a 18% CAGR over the last five years","url":"https://stock-news.laohu8.com/highlight/detail?id=2477040170","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477040170?lang=en_us&edition=fundamental","pubTime":"2024-10-21 08:44","pubTimestamp":1729471459,"startTime":"0","endTime":"0","summary":"It hasn't been the best quarter for Proteomics International Laboratories Ltd  shareholders, since the share price has fallen 14% in that time. But that scarcely detracts from the really solid long term returns generated by the company over five years. It's fair to say most would be happy with 126% the gain in that time. We think it's more important to dwell on the long term returns than the short term returns. The more important question is whether the stock is too cheap or too expensive today.So let's investigate and see if the longer term performance of the company has been in line with the underlying business' progress.See our latest analysis for Proteomics International Laboratories","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/qUsXHnhTq9BjFq.vX6I3sw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b7362375b2727bfdfe4eb144bcc3fe6a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/qUsXHnhTq9BjFq.vX6I3sw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b7362375b2727bfdfe4eb144bcc3fe6a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/proteomics-international-laboratories-asx-piq-004419783.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7048","PIQ.AU","BK7508"],"gpt_icon":0},{"id":"2469132528","title":"BUZZ-Australia's Proteomics International Laboratories rises on positive cancer study results","url":"https://stock-news.laohu8.com/highlight/detail?id=2469132528","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2469132528?lang=en_us&edition=fundamental","pubTime":"2024-09-23 10:58","pubTimestamp":1727060332,"startTime":"0","endTime":"0","summary":"** Shares of Proteomics International Labs    rise as much as 8.4% to A$0.71   ** The medical technology co says its PromarkerEso blood test for esophageal adenocarcinoma shows 94% accuracy in clinical validation study   ** Co says esophageal adenocarcinoma, a cancer arising in the food pipe, is among the leading cause of cancer-related deaths, with a 5-year survival rate of 20%, due to late diagnosis   ** Says improved surveillance of at-risk patients using PromarkerEso could enable earlier diagnosis and significantly improve health outcomes   ** Stock has fallen 26.8% this year, as of last close ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XKO.AU","BK7508","PIQ.AU","BK7048","XAO.AU","XJO.AU"],"gpt_icon":0},{"id":"2467730008","title":"Proteomics Investors Face 'Considerable Unknowns' After Kidney Diagnostics License Canceled, Says Euroz Hartleys","url":"https://stock-news.laohu8.com/highlight/detail?id=2467730008","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467730008?lang=en_us&edition=fundamental","pubTime":"2024-09-13 06:17","pubTimestamp":1726179468,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  investors are left with \"considerable unknowns\" after the medical technology business terminated its exclusive license with Sonic Healthcare USA for its PromarkerD kidney disease diagnostic tool, according to a Wednesday note from Euroz Hartleys.The license was canceled after certain milestones were not met, with the US launch now slated for 2025, targeting alternative pathology labs and service providers, and direct to consumers and patients.While Proteomics has partners for Europe and other territories for PromarkerD, not commercializing in the US healthcare market, the world's largest, has lost potentially 32 million patients and potential users of the test, the investment firm said.Euroz Hartleys downgraded Proteomics to hold from speculative buy and lowered the price target to AU$0.73 price target from AU$1.10 on increased uncertainties around the commercialization of PromarkerD in the US.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4211","PIQ.AU","ISBC","BK7508","BK7048"],"gpt_icon":0},{"id":"2467073007","title":"Proteomics Investors Face 'Considerable Unknowns' After Kidney Diagnostics License Canceled, Says Euroz Hartleys","url":"https://stock-news.laohu8.com/highlight/detail?id=2467073007","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467073007?lang=en_us&edition=fundamental","pubTime":"2024-09-13 06:17","pubTimestamp":1726179468,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["HCSG","ISBC","PIQ.AU","BK7048","BK7508","BK7124","BK4137","SHL.AU","BK4211"],"gpt_icon":0},{"id":"2466720244","title":"Euroz Hartleys Downgrades Proteomics International Laboratories to Hold from Speculative Buy, Adjusts Price Target to AU$0.73 From AU$1.10","url":"https://stock-news.laohu8.com/highlight/detail?id=2466720244","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466720244?lang=en_us&edition=fundamental","pubTime":"2024-09-12 15:45","pubTimestamp":1726127111,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4125","BK7048","PIQ.AU","AUD","BK7508"],"gpt_icon":0},{"id":"2466244717","title":"Euroz Hartleys Downgrades Proteomics International Laboratories to Hold from Speculative Buy, Adjusts Price Target to AU$0.73 From AU$1.10","url":"https://stock-news.laohu8.com/highlight/detail?id=2466244717","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466244717?lang=en_us&edition=fundamental","pubTime":"2024-09-12 15:45","pubTimestamp":1726127111,"startTime":"0","endTime":"0","summary":"Price (AUD): $0.63, Change: $-0.070, Percent Change: -10.00%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PIQ.AU"],"gpt_icon":0},{"id":"2466423651","title":"ASX Market Update: Mineral Resources leads local bourse higher as US debate draws no Aussie reaction | September 11, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2466423651","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466423651?lang=en_us&edition=fundamental","pubTime":"2024-09-11 11:20","pubTimestamp":1726024800,"startTime":"0","endTime":"0","summary":"The ASX200 has been down 0.3% at 7,988 points in early afternoon trade.Gold prices have climbed back to record levels during the US Trump-Harris Presidential debate on Wednesday morning, just under $2,520 per ounce American.Futures for the S&P500 also dipped during the debate, falling from minus 12 points to minus 21 points.The ASX200 didn’t appear to react to the debate, continuing to trade flat.Melbana Energy  has been up more than 56% after approval to develop its “Block 9” area of interest in Cuba.Catalyst Metals has been up more than 6% on the back of the 1Moz resource it’s grown over the last 12 months. This boosts three year gold production guidance by one hundred thousand ounces and total guidance to 200K ounces.Proteomics International Labs  has been down more than 18% after terminating its licence agreement with Sonic Healthcare in the United States. The company plans to licence with another provide and potentially sell direct to consumers.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-update-mineral-resources-leads-local-bourse-higher-as-us-debate-draws-no-aussie-reaction-september-11-2024-2024-09-11/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7508","BK7048","MAY.AU","BK7142","PIQ.AU","BK7104","CYL.AU"],"gpt_icon":0}],"pageSize":16,"totalPage":2,"pageCount":1,"totalSize":22}]}}